![Suicide Risk From Weight-Loss Drugs Prompts More EU Questions](/i/c/7434225d-8019-49e0-e60e-48edc6576aaf.webp)
Suicide Risk From Weight-Loss Drugs Prompts More EU Questions
The European Union’s drugs regulator has asked pharma companies including Novo Nordisk A/S and Eli Lilly & Co.
2023-12-01 23:17
![Altimmune Jumps 66% After Positive Results for Its Obesity Drug](/i/c/33ec74d1-492f-7c7d-ffb4-f240617d6e98.webp)
Altimmune Jumps 66% After Positive Results for Its Obesity Drug
Altimmune Inc. jumped as much as 66% in late trading after the biotech company reported results from a
2023-12-01 07:26
![Long-Time Novo Bull Slashes Stake Citing Weight-Loss Drug Hype](/i/c/32037065-74bb-c443-2df3-4bf6e5acbd1a.webp)
Long-Time Novo Bull Slashes Stake Citing Weight-Loss Drug Hype
A top-performing European fund manager is calling time on “hype” around weight-loss drugs that has sent Novo Nordisk
2023-11-27 16:52
![Ozempic Maker Novo Nordisk Invests $2.3 Billion in France Site](/i/c/2a4fb381-81a5-9ca5-4543-4f3ea8c785a3.webp)
Ozempic Maker Novo Nordisk Invests $2.3 Billion in France Site
Novo Nordisk A/S, which faces supply bottlenecks amid high demand for its blockbuster weight-loss medicines, will invest €2.1
2023-11-23 14:22
![Novo Nordisk Staff Get Free Wegovy As a Perk If They Need It](/i/c/a29c58f2-be58-b718-5611-da2eb42698ca.webp)
Novo Nordisk Staff Get Free Wegovy As a Perk If They Need It
If you’re a Novo Nordisk A/S employee with obesity, you will have access to a unique company perk:
2023-11-16 00:24
![Germany Mulls Obesity Drug Export Ban as EU Confronts Shortage](/i/c/891bfe09-7305-a3aa-0e83-a8d4526fb58f.webp)
Germany Mulls Obesity Drug Export Ban as EU Confronts Shortage
Germany is considering an export ban on Novo Nordisk A/S’s blockbuster weight-loss drugs as European countries try to
2023-11-15 18:54
![Novo Shares Rise After Wegovy Demonstrates Heart Benefit in Trial](/i/c/252228df-9dfb-5e13-7107-56da386bdb76.webp)
Novo Shares Rise After Wegovy Demonstrates Heart Benefit in Trial
Novo Nordisk A/S gained another $14.5 billion of market value after a key study backed the use of
2023-11-13 20:54
![Trump’s Bet in Iowa, Wegovy Study: Your Saturday US Briefing](/i/c/536b070b-d2de-27b2-a5d4-c3e1ce86e427.webp)
Trump’s Bet in Iowa, Wegovy Study: Your Saturday US Briefing
Good morning from Washington, where Congress is up against a Nov. 17 deadline when government funding runs out.Donald
2023-11-12 01:49
![Wegovy Study Bolsters Use In Patients With Obesity and Heart Disease](/i/c/028b34ab-a51e-4fc1-4f5e-d4ba8dad29f8.webp)
Wegovy Study Bolsters Use In Patients With Obesity and Heart Disease
Novo Nordisk A/S unveiled details from a closely watched study that support use of Wegovy, its blockbuster weight-loss
2023-11-11 21:53
![Weight-Loss Drugs Among the Most Sought-After New Corporate Benefits](/i/c/6671c1c1-ea6e-3746-5d05-2f50678ec438.webp)
Weight-Loss Drugs Among the Most Sought-After New Corporate Benefits
The craze around pricey weight-loss drugs has many people clamoring for these treatments in company-sponsored health plans. While
2023-11-11 00:59
![Novo to Build $6 Billion Plant as Obesity Drug Demand Surges](/i/c/0ab5a5e3-f5c1-1286-e9e4-6e08689617c6.webp)
Novo to Build $6 Billion Plant as Obesity Drug Demand Surges
Novo Nordisk A/S will invest more than 42 billion kroner ($6 billion) to expand its manufacturing facilities as
2023-11-10 21:23
![Astra Enters Obesity Drug Race With Chinese Biotech Deal](/i/c/abc22a8e-b091-081c-a70a-374aa7d16daa.webp)
Astra Enters Obesity Drug Race With Chinese Biotech Deal
AstraZeneca Plc clinched a deal to develop a drug from the pharma industry’s hottest class of medicines, agreeing
2023-11-09 18:49